Compile Data Set for Download or QSAR
Found 9 of ic50 for monomerid = 256611
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Respivert Limited

US Patent
LigandPNGBDBM256611(US10435361, Example 85(m) | US9481648, 85(m) | US9...)
Affinity DataIC50:  72nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Respivert Limited

US Patent
LigandPNGBDBM256611(US10435361, Example 85(m) | US9481648, 85(m) | US9...)
Affinity DataIC50:  72nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Respivert Limited

US Patent
LigandPNGBDBM256611(US10435361, Example 85(m) | US9481648, 85(m) | US9...)
Affinity DataIC50:  72nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Respivert Limited

US Patent
LigandPNGBDBM256611(US10435361, Example 85(m) | US9481648, 85(m) | US9...)
Affinity DataIC50:  1.19E+3nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Respivert Limited

US Patent
LigandPNGBDBM256611(US10435361, Example 85(m) | US9481648, 85(m) | US9...)
Affinity DataIC50:  1.19E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Respivert Limited

US Patent
LigandPNGBDBM256611(US10435361, Example 85(m) | US9481648, 85(m) | US9...)
Affinity DataIC50:  1.19E+3nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 alpha(Homo sapiens (Human))
Respivert Limited

US Patent
LigandPNGBDBM256611(US10435361, Example 85(m) | US9481648, 85(m) | US9...)
Affinity DataIC50:  1.03E+4nMAssay Description:The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 alpha(Homo sapiens (Human))
Respivert Limited

US Patent
LigandPNGBDBM256611(US10435361, Example 85(m) | US9481648, 85(m) | US9...)
Affinity DataIC50:  1.03E+4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 alpha(Homo sapiens (Human))
Respivert Limited

US Patent
LigandPNGBDBM256611(US10435361, Example 85(m) | US9481648, 85(m) | US9...)
Affinity DataIC50:  1.03E+4nMAssay Description:Method 2: This method follows the same steps as Method 1 above, but utilises a shorter period of mixing of the test compound (105 minutes instead of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent